table of content
1 Study Coverage
1.1 IBS-C Drugs Product Introduction
1.2 Global IBS-C Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global IBS-C Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global IBS-C Drugs Sales in Volume for the Year 2017-2028
1.3 United States IBS-C Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States IBS-C Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States IBS-C Drugs Sales in Volume for the Year 2017-2028
1.4 IBS-C Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States IBS-C Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of IBS-C Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 IBS-C Drugs Market Dynamics
1.5.1 IBS-C Drugs Industry Trends
1.5.2 IBS-C Drugs Market Drivers
1.5.3 IBS-C Drugs Market Challenges
1.5.4 IBS-C Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 IBS-C Drugs Market Segment by Type
2.1.1 Linaclotide
2.1.2 Lubiprostone
2.1.3 Osmotic Laxatives
2.1.4 Stimulant Laxatives
2.1.5 Others
2.2 Global IBS-C Drugs Market Size by Type
2.2.1 Global IBS-C Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global IBS-C Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global IBS-C Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States IBS-C Drugs Market Size by Type
2.3.1 United States IBS-C Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States IBS-C Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States IBS-C Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 IBS-C Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global IBS-C Drugs Market Size by Application
3.2.1 Global IBS-C Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global IBS-C Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global IBS-C Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States IBS-C Drugs Market Size by Application
3.3.1 United States IBS-C Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States IBS-C Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States IBS-C Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global IBS-C Drugs Competitor Landscape by Company
4.1 Global IBS-C Drugs Market Size by Company
4.1.1 Top Global IBS-C Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global IBS-C Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global IBS-C Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global IBS-C Drugs Price by Manufacturer (2017-2022)
4.2 Global IBS-C Drugs Concentration Ratio (CR)
4.2.1 IBS-C Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of IBS-C Drugs in 2021
4.2.3 Global IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global IBS-C Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global IBS-C Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers IBS-C Drugs Product Type
4.3.3 Date of International Manufacturers Enter into IBS-C Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States IBS-C Drugs Market Size by Company
4.5.1 Top IBS-C Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States IBS-C Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States IBS-C Drugs Sales by Players (2020, 2021 & 2022)
5 Global IBS-C Drugs Market Size by Region
5.1 Global IBS-C Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global IBS-C Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global IBS-C Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global IBS-C Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global IBS-C Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global IBS-C Drugs Sales in Value by Region: 2017-2022
5.3.2 Global IBS-C Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America IBS-C Drugs Market Size YoY Growth 2017-2028
6.1.2 North America IBS-C Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific IBS-C Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific IBS-C Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe IBS-C Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe IBS-C Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America IBS-C Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America IBS-C Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa IBS-C Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa IBS-C Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Catalent Pharmaceuticals Solutions
7.1.1 Catalent Pharmaceuticals Solutions Corporation Information
7.1.2 Catalent Pharmaceuticals Solutions Description and Business Overview
7.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Products Offered
7.1.5 Catalent Pharmaceuticals Solutions Recent Development
7.2 Nestle
7.2.1 Nestle Corporation Information
7.2.2 Nestle Description and Business Overview
7.2.3 Nestle IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Nestle IBS-C Drugs Products Offered
7.2.5 Nestle Recent Development
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporation Information
7.3.2 Abbott Laboratories Description and Business Overview
7.3.3 Abbott Laboratories IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Abbott Laboratories IBS-C Drugs Products Offered
7.3.5 Abbott Laboratories Recent Development
7.4 Synergy Pharmaceuticals
7.4.1 Synergy Pharmaceuticals Corporation Information
7.4.2 Synergy Pharmaceuticals Description and Business Overview
7.4.3 Synergy Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Synergy Pharmaceuticals IBS-C Drugs Products Offered
7.4.5 Synergy Pharmaceuticals Recent Development
7.5 Sucampo Pharmaceuticals
7.5.1 Sucampo Pharmaceuticals Corporation Information
7.5.2 Sucampo Pharmaceuticals Description and Business Overview
7.5.3 Sucampo Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sucampo Pharmaceuticals IBS-C Drugs Products Offered
7.5.5 Sucampo Pharmaceuticals Recent Development
7.6 Novartis Pharma Ag
7.6.1 Novartis Pharma Ag Corporation Information
7.6.2 Novartis Pharma Ag Description and Business Overview
7.6.3 Novartis Pharma Ag IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Novartis Pharma Ag IBS-C Drugs Products Offered
7.6.5 Novartis Pharma Ag Recent Development
7.7 Astellas Pharmaceuticals
7.7.1 Astellas Pharmaceuticals Corporation Information
7.7.2 Astellas Pharmaceuticals Description and Business Overview
7.7.3 Astellas Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Astellas Pharmaceuticals IBS-C Drugs Products Offered
7.7.5 Astellas Pharmaceuticals Recent Development
7.8 Ardelyx, Inc
7.8.1 Ardelyx, Inc Corporation Information
7.8.2 Ardelyx, Inc Description and Business Overview
7.8.3 Ardelyx, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Ardelyx, Inc IBS-C Drugs Products Offered
7.8.5 Ardelyx, Inc Recent Development
7.9 Synthetic Biologics, Inc
7.9.1 Synthetic Biologics, Inc Corporation Information
7.9.2 Synthetic Biologics, Inc Description and Business Overview
7.9.3 Synthetic Biologics, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Synthetic Biologics, Inc IBS-C Drugs Products Offered
7.9.5 Synthetic Biologics, Inc Recent Development
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Corporation Information
7.10.2 Teva Pharmaceutical Industries Description and Business Overview
7.10.3 Teva Pharmaceutical Industries IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Teva Pharmaceutical Industries IBS-C Drugs Products Offered
7.10.5 Teva Pharmaceutical Industries Recent Development
7.11 Bama-Geve, SLU
7.11.1 Bama-Geve, SLU Corporation Information
7.11.2 Bama-Geve, SLU Description and Business Overview
7.11.3 Bama-Geve, SLU IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Bama-Geve, SLU IBS-C Drugs Products Offered
7.11.5 Bama-Geve, SLU Recent Development
7.12 Ferring BV
7.12.1 Ferring BV Corporation Information
7.12.2 Ferring BV Description and Business Overview
7.12.3 Ferring BV IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Ferring BV Products Offered
7.12.5 Ferring BV Recent Development
7.13 Ironwood Pharmaceuticals, Inc
7.13.1 Ironwood Pharmaceuticals, Inc Corporation Information
7.13.2 Ironwood Pharmaceuticals, Inc Description and Business Overview
7.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Ironwood Pharmaceuticals, Inc Products Offered
7.13.5 Ironwood Pharmaceuticals, Inc Recent Development
7.14 Salix Pharmaceuticals Ltd
7.14.1 Salix Pharmaceuticals Ltd Corporation Information
7.14.2 Salix Pharmaceuticals Ltd Description and Business Overview
7.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Salix Pharmaceuticals Ltd Products Offered
7.14.5 Salix Pharmaceuticals Ltd Recent Development
7.15 Norgine B.V
7.15.1 Norgine B.V Corporation Information
7.15.2 Norgine B.V Description and Business Overview
7.15.3 Norgine B.V IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Norgine B.V Products Offered
7.15.5 Norgine B.V Recent Development
7.16 Prometheus Laboratories Inc
7.16.1 Prometheus Laboratories Inc Corporation Information
7.16.2 Prometheus Laboratories Inc Description and Business Overview
7.16.3 Prometheus Laboratories Inc IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Prometheus Laboratories Inc Products Offered
7.16.5 Prometheus Laboratories Inc Recent Development
7.17 Actavis Nordic A/S
7.17.1 Actavis Nordic A/S Corporation Information
7.17.2 Actavis Nordic A/S Description and Business Overview
7.17.3 Actavis Nordic A/S IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Actavis Nordic A/S Products Offered
7.17.5 Actavis Nordic A/S Recent Development
7.18 Albireo Pharma Inc
7.18.1 Albireo Pharma Inc Corporation Information
7.18.2 Albireo Pharma Inc Description and Business Overview
7.18.3 Albireo Pharma Inc IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Albireo Pharma Inc Products Offered
7.18.5 Albireo Pharma Inc Recent Development
7.19 Yuhan Corp
7.19.1 Yuhan Corp Corporation Information
7.19.2 Yuhan Corp Description and Business Overview
7.19.3 Yuhan Corp IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Yuhan Corp Products Offered
7.19.5 Yuhan Corp Recent Development
7.20 Astrazeneca Plc
7.20.1 Astrazeneca Plc Corporation Information
7.20.2 Astrazeneca Plc Description and Business Overview
7.20.3 Astrazeneca Plc IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Astrazeneca Plc Products Offered
7.20.5 Astrazeneca Plc Recent Development
7.21 The Menarini Group
7.21.1 The Menarini Group Corporation Information
7.21.2 The Menarini Group Description and Business Overview
7.21.3 The Menarini Group IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.21.4 The Menarini Group Products Offered
7.21.5 The Menarini Group Recent Development
7.22 Ono Pharmaceutical Co., Ltd
7.22.1 Ono Pharmaceutical Co., Ltd Corporation Information
7.22.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
7.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2017-2022)
7.22.4 Ono Pharmaceutical Co., Ltd Products Offered
7.22.5 Ono Pharmaceutical Co., Ltd Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 IBS-C Drugs Industry Chain Analysis
8.2 IBS-C Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 IBS-C Drugs Distributors
8.3 IBS-C Drugs Production Mode & Process
8.4 IBS-C Drugs Sales and Marketing
8.4.1 IBS-C Drugs Sales Channels
8.4.2 IBS-C Drugs Distributors
8.5 IBS-C Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
